LFWD (Lifeward) Moat Score: 2/10 (As of Jun. 27, 2026)


LFWD Lifeward Ltd LFWD
56 GF Score
Price $7.20
GF Value $13.73
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Lifeward Moat Score?

Lifeward LFWD +3.90% 56 Moat Score is 2 as of Jun. 27, 2026. GuruFocus rates LFWD with a GF Score™ of 56/100 and a GF Value™ of $13.73 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Lifeward ranks better than 68.09% on this metric.

Lifeward has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Lifeward has No Moat: Lifeward Ltd has minimal market share and lacks significant network effects or customer switching costs. The company does not have valuable patents or a strong brand, and it faces intense competition with no clear cost advantages or regulatory barriers.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Lifeward might have No Moat - Very weak/transient advantages.

Lifeward  (NAS:LFWD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Lifeward Moat Score Related Terms

LFWD vs GTHP, VNRX, IRIX: Moat Score Comparison

For the Medical Devices subindustry, Lifeward's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifeward Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeward's Moat Score distribution charts can be found below:

* The bar in red indicates where Lifeward's Moat Score falls into.


LFWD
56GF Score
Lifeward Ltd LFWD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Lifeward (LFWD) has a Moat Score of 2 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Lifeward ranks #270 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 31.9%.
Is Lifeward's Moat Score too high?
Lifeward's current Moat Score is 2. Based on the distribution chart, Lifeward ranks #270 out of 846 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lifeward has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifeward's Moat Score compare to GTHP and VNRX?
According to the Medical Devices & Instruments industry distribution chart, Lifeward ranks #270 out of 846 companies for Moat Score. This puts Lifeward in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Lifeward's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifeward stock overvalued right now?
Based on GuruFocus' analysis, Lifeward (LFWD) is currently considered Possible Value Trap. The stock's GF Value™ is $13.73, compared to a current price of $7.20 — trading 47.6% below its estimated fair value. The current Moat Score is 2. Lifeward's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Lifeward (LFWD), the current Moat Score is 2 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifeward (LFWD) Overvalued in 2026?

Based on GuruFocus' analysis, Lifeward stock appears to be undervalued. The current stock price of $7.20 is trading 47.6% below its estimated GF Value™ of $13.73. GuruFocus considers Lifeward to be Possible Value Trap.

Key valuation signals for LFWD:

  • Moat Score: 2
  • GF Value™: $13.73 vs. price of $7.20 (47.6% below fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the LFWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifeward Business Description

Address 2 Cabot Road, Hudson, MA, USA, 01749
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
56GF Score

Get the complete analysis for LFWD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.20
Price
$13.73
GF Value